课题基金 / 基金详情

Developing and validating NAFLD advanced fibrosis diagnostic prediction model in primary care

Developing and validating NAFLD advanced fibrosis diagnostic prediction model in primary care
在初级保健中开发和验证 NAFLD 高级纤维化诊断预测模型
批准号:
402930
负责人:
Shaheen Abdel-Aziz M
金额:
$19.84万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-03-01 至 2023-03-01

项目摘要

项目成果

Shaheen Abdel-Aziz M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Non-alcoholic fatty liver disease (NAFLD), commonly called fatty liver, has become the leading cause of chronic liver disease in North America. It is estimated that up to 24% of Canadian population has NAFLD. NAFLD will become the main cause of end stage
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluate, validate and refine the first clinical care pathway to risk-stratify patients with alcohol-related liver disease
  • 批准号:
    470000
  • 项目类别:
    Operating Grants
  • 资助金额:
    $33.16万
  • 财政年份:
    2022
  • 负责人:
    Shaheen Abdel-Aziz M
  • 依托单位:
Understanding and Responding to the COVID-19 Pandemic Effect on the Magnitude of Alcohol-Related Liver Disease in Alberta.
  • 批准号:
    460228
  • 项目类别:
    Operating Grants
  • 资助金额:
    $30.81万
  • 财政年份:
    2021
  • 负责人:
    Shaheen Abdel-Aziz M
  • 依托单位:
海外基金